Retinal Development: Genetics

This feed focuses on genetic, epigenetic, and transcriptomic processes pertaining to retinal development and aging.

January 19, 2021
Open Access

Clinical manifestation and genetic analysis in Chinese early onset X-linked retinoschisis

Molecular Genetics & Genomic Medicine
Li HuangXiaoyan Ding
January 17, 2021
Open Access

SPOAN syndrome: a novel mutation and new ocular findings; a case report

BMC Neurology
Fatemeh BazvandAlireza Mahmoudi
January 16, 2021
Open Access

Evaluation of choroidal thickness in children with type 1 diabetes: the role of optical coherence tomography in diabetic retinopathy screening

Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology
Basak Can ErmerakAhmet Ali Yucel
January 19, 2021
Review

Recent progress in the use of microRNAs as biomarkers for drug-induced toxicities in contrast to traditional biomarkers: A comparative review

Drug Metabolism and Pharmacokinetics
Shingo Oda, Tsuyoshi Yokoi
January 16, 2021
Review

Ranibizumab: A Review in Retinopathy of Prematurity

Paediatric Drugs
Arnold Lee, Matt Shirley
January 16, 2021
Open Access

Association of P10L Polymorphism in Melanopsin Gene with Chronic Insomnia in Mexicans

International Journal of Environmental Research and Public Health
Bianca Ethel Gutiérrez-AmavizcaJorge Alberto Pérez-León
January 16, 2021

Host immune responses after suprachoroidal delivery of AAV8 in nonhuman primate eyes

Human Gene Therapy
Sook Hyun ChungGlenn Yiu
January 17, 2021

The T414G mitochondrial DNA mutation: a biomarker of aging in human eye

Mutagenesis
Anne-Sophie GaryPatrick J Rochette
January 16, 2021

Multimodal Imaging in the Diagnosis of Exophytic Juxtapapillary Retinal Capillary Hemangioblastoma

American Journal of Ophthalmology
Jonathan F RussellJ William Harbour
January 17, 2021

A bispecific single domain antibody boosts autologous Vγ9Vδ2-T cell responses towards CD1d in chronic lymphocytic leukemia

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Iris de WeerdtHans J van der Vliet
January 16, 2021

X-linked dominant RPGR gene mutation in a familial Coats angiomatosis

BMC Ophthalmology
Marcella NebbiosoEnrica Marchionni
January 16, 2021

Breast Cancer in Adolescent and Young Adult Women Under the Age of 40 Years

JCO Oncology Practice
Elizabeth J Cathcart-RakeRebecca H Johnson

Sign up to follow this feed and discover related papers.

Related Feeds

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

CRISPR & Single Cell Analyses

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on CRISPR-Cas applications relevant to single cell analyses. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

© 2021 Meta ULC. All rights reserved
/feed-previews/retinal-development-genetics/455a5eb0-1020-4c2e-a364-ac5c536a69e2